Published in J Biol Chem on January 05, 2009
PPARγ signaling and metabolism: the good, the bad and the future. Nat Med (2013) 3.71
Propagation of adipogenic signals through an epigenomic transition state. Genes Dev (2010) 2.23
Human resistin: found in translation from mouse to man. Trends Endocrinol Metab (2011) 1.51
Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis. J Biol Chem (2011) 1.15
A novel adipose-specific gene deletion model demonstrates potential pitfalls of existing methods. Mol Endocrinol (2012) 1.13
Mediator-dependent nuclear receptor function. Semin Cell Dev Biol (2011) 1.12
Resistin in rodents and humans. Diabetes Metab J (2013) 1.03
Cytokines in the Progression of Pancreatic β-Cell Dysfunction. Int J Endocrinol (2010) 0.99
Novel insights into adipogenesis from omics data. Curr Med Chem (2009) 0.95
Peroxisome proliferator-activated receptor γ and C/EBPα synergistically activate key metabolic adipocyte genes by assisted loading. Mol Cell Biol (2013) 0.94
A protective strategy against hyperinflammatory responses requiring the nontranscriptional actions of GPS2. Mol Cell (2012) 0.90
Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice. Diabetes (2011) 0.90
GPS2/KDM4A pioneering activity regulates promoter-specific recruitment of PPARγ. Cell Rep (2014) 0.84
Nuclear receptors and metabolism: from feast to famine. Diabetologia (2014) 0.84
Age-related autocrine diabetogenic effects of transgenic resistin in spontaneously hypertensive rats: gene expression profile analysis. Physiol Genomics (2011) 0.81
Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma). PLoS One (2010) 0.81
Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer. World J Gastroenterol (2016) 0.81
Fam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesis. J Biol Chem (2012) 0.78
Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". Hepat Mon (2014) 0.78
Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings. Clin Exp Med (2016) 0.77
Nutrigenomic Functions of PPARs in Obesogenic Environments. PPAR Res (2016) 0.76
HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus. Front Microbiol (2017) 0.75
Linking resistin, inflammation, and cardiometabolic diseases. Korean J Intern Med (2017) 0.75
Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease. Biomed Rep (2017) 0.75
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet (2007) 32.41
Genomic maps and comparative analysis of histone modifications in human and mouse. Cell (2005) 18.96
Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet (2008) 18.28
The hormone resistin links obesity to diabetes. Nature (2001) 15.49
PRDM16 controls a brown fat/skeletal muscle switch. Nature (2008) 13.08
A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res (2003) 12.94
Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol (2006) 11.36
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev (1991) 11.10
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev (1994) 10.44
Adipocytes as regulators of energy balance and glucose homeostasis. Nature (2006) 9.52
Transcriptional control of adipocyte formation. Cell Metab (2006) 9.50
Transcriptional control of brown fat determination by PRDM16. Cell Metab (2007) 6.79
C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev (2002) 6.46
Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev (1995) 6.03
Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev (1989) 5.59
Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev (2008) 4.93
Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell (1999) 4.89
DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol (2008) 4.56
A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev (1991) 4.50
Adipose tissue as an endocrine organ. Trends Endocrinol Metab (2000) 4.07
Species-specific transcription in mice carrying human chromosome 21. Science (2008) 4.03
CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci U S A (1991) 3.98
Multiple forms of the human gene-specific transcription factor USF. I. Complete purification and identification of USF from HeLa cell nuclei. J Biol Chem (1988) 3.96
Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev (2008) 3.90
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J (2000) 3.81
Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev (1995) 3.63
Regulation of fasted blood glucose by resistin. Science (2004) 3.54
Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun (2003) 3.16
PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol (1995) 3.14
Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest (2003) 3.11
A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A (2001) 2.93
Tissue-specific enhancer of the human glycoprotein hormone alpha-subunit gene: dependence on cyclic AMP-inducible elements. Mol Cell Biol (1987) 2.80
Genome-wide prediction of conserved and nonconserved enhancers by histone acetylation patterns. Genome Res (2006) 2.67
Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha. Nucleic Acids Res (1994) 2.58
An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med (2004) 2.51
Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes (2001) 2.43
Transcriptional regulation by C-terminal binding proteins. Int J Biochem Cell Biol (2007) 2.28
Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab (2003) 2.25
Induction of Rev-ErbA alpha, an orphan receptor encoded on the opposite strand of the alpha-thyroid hormone receptor gene, during adipocyte differentiation. J Biol Chem (1993) 1.96
CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. Biochem Biophys Res Commun (1997) 1.94
Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein alpha. Proc Natl Acad Sci U S A (1996) 1.92
The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet (2004) 1.91
Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res (2002) 1.86
Insulin regulates transcription of the CCAAT/enhancer binding protein (C/EBP) alpha, beta, and delta genes in fully-differentiated 3T3-L1 adipocytes. J Biol Chem (1995) 1.77
Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res (2004) 1.70
Molecular determinants of brown adipocyte formation and function. Genes Dev (2008) 1.68
The role of the CCAAT/enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP). Mol Cell Biol (1990) 1.67
Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun (2003) 1.59
Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab (2002) 1.56
Resistin, central obesity, and type 2 diabetes. Lancet (2002) 1.56
A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood (2003) 1.49
Glucocorticoids reciprocally regulate expression of the CCAAT/enhancer-binding protein alpha and delta genes in 3T3-L1 adipocytes and white adipose tissue. J Biol Chem (1994) 1.46
Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter. J Biol Chem (1997) 1.42
Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. Mol Endocrinol (2002) 1.40
A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes (2003) 1.40
Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes (2004) 1.39
Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2. Mol Endocrinol (2002) 1.37
Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care (2007) 1.34
Resistin- and Obesity-associated metabolic diseases. Horm Metab Res (2007) 1.24
Mechanisms regulating adipocyte expression of resistin. J Biol Chem (2002) 1.24
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun (2005) 1.07
Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia (2004) 1.07
Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis (2003) 1.02
Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab (2002) 0.97
Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone. J Clin Endocrinol Metab (2005) 0.93
Sp1 mediates repression of the resistin gene by PPARgamma agonists in 3T3-L1 adipocytes. Biochem Biophys Res Commun (2006) 0.89
Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha. Mol Endocrinol (2003) 0.89
Resistin: a new link between obesity and insulin resistance? Clin Endocrinol (Oxf) (2001) 0.86
The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus. Metabolism (2005) 0.84
Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes. Clin Endocrinol (Oxf) (2008) 0.81
The many faces of PPARgamma. Cell (2005) 6.24
A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science (2011) 5.91
Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell (2002) 5.19
PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev (2008) 4.83
Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol (2011) 4.72
Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science (2007) 4.68
DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol (2008) 4.56
Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev (2007) 4.23
Physiology. The health risk of obesity--better metrics imperative. Science (2013) 4.19
Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest (2004) 4.16
Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev (2008) 3.90
Regulation of fasted blood glucose by resistin. Science (2004) 3.54
Resistin is an inflammatory marker of atherosclerosis in humans. Circulation (2005) 3.52
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev (2006) 3.48
New developments in adipogenesis. Trends Endocrinol Metab (2009) 3.44
Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. Genes Dev (2005) 3.30
Chromatin decouples promoter threshold from dynamic range. Nature (2008) 3.24
Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature (2008) 3.23
A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med (2002) 3.22
HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci (2011) 3.06
RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci U S A (2004) 3.05
Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. Genes Dev (2012) 2.83
Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science (2006) 2.62
Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab (2001) 2.54
An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med (2004) 2.51
Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages. Mol Cell Biol (2010) 2.47
The orphan nuclear receptor Rev-erbalpha recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene. Mol Endocrinol (2005) 2.36
Propagation of adipogenic signals through an epigenomic transition state. Genes Dev (2010) 2.23
International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol Rev (2006) 2.22
The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol Cell Biol (2003) 2.15
Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol (2007) 2.10
The current biology of resistin. J Intern Med (2004) 2.06
International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev (2006) 2.04
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol Sci (2004) 1.97
Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response. J Cell Biol (2003) 1.92
Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med (2012) 1.87
CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. J Am Coll Cardiol (2007) 1.87
Clocks, metabolism, and the epigenome. Mol Cell (2012) 1.84
The orphan nuclear receptor Rev-erb alpha regulates circadian expression of plasminogen activator inhibitor type 1. J Biol Chem (2006) 1.73
A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. Genes Dev (2006) 1.70
Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol (2008) 1.66
Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J Clin Invest (2006) 1.66
Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest (2009) 1.63
A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation. EMBO J (2003) 1.62
PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metab (2007) 1.61
PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension (2005) 1.60
Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev Cell (2003) 1.60
Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature (2013) 1.59
Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter. J Biol Chem (2005) 1.57
Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. Genes Dev (2011) 1.54
Assembly of the SMRT-histone deacetylase 3 repression complex requires the TCP-1 ring complex. Genes Dev (2002) 1.53
Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology (2003) 1.53
Human resistin: found in translation from mouse to man. Trends Endocrinol Metab (2011) 1.51
Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas. Mol Endocrinol (2009) 1.49
PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. J Clin Invest (2005) 1.49
Bifunctional role of Rev-erbalpha in adipocyte differentiation. Mol Cell Biol (2008) 1.45
Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo. Nat Struct Mol Biol (2013) 1.43
GSK4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbα. ACS Chem Biol (2010) 1.41
Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes (2006) 1.40
Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes (2004) 1.39
Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2. Mol Endocrinol (2002) 1.37
Inflamed about obesity. Nat Med (2004) 1.37
Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors. Proc Natl Acad Sci U S A (2005) 1.35
ETO interacting proteins. Oncogene (2004) 1.35
Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J Immunol (2010) 1.31
Negative feedback maintenance of heme homeostasis by its receptor, Rev-erbalpha. Genes Dev (2009) 1.30
Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J Clin Invest (2012) 1.29
Dissociating fatty liver and diabetes. Trends Endocrinol Metab (2012) 1.29
Brown fat in humans: turning up the heat on obesity. Diabetes (2009) 1.28
Central resistin induces hepatic insulin resistance via neuropeptide Y. J Neurosci (2007) 1.28
The histone-binding code of nuclear receptor co-repressors matches the substrate specificity of histone deacetylase 3. EMBO Rep (2005) 1.28
Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation. Nat Med (2008) 1.27
Activation of SOCS-3 by resistin. Mol Cell Biol (2005) 1.27
Nuclear receptor Rev-erbalpha: a heme receptor that coordinates circadian rhythm and metabolism. Nucl Recept Signal (2010) 1.27
Species-specific strategies underlying conserved functions of metabolic transcription factors. Mol Endocrinol (2011) 1.25
Re-expression of GATA2 cooperates with peroxisome proliferator-activated receptor-gamma depletion to revert the adipocyte phenotype. J Biol Chem (2009) 1.24
Mechanisms regulating adipocyte expression of resistin. J Biol Chem (2002) 1.24
Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ. Proc Natl Acad Sci U S A (2013) 1.24
Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue. Diabetes (2006) 1.23
E3 ligases Arf-bp1 and Pam mediate lithium-stimulated degradation of the circadian heme receptor Rev-erb alpha. Proc Natl Acad Sci U S A (2010) 1.23
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist. Mol Endocrinol (2007) 1.22
Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis. Diabetes (2011) 1.15
Differential action on coregulator interaction defines inverse retinoid agonists and neutral antagonists. Chem Biol (2009) 1.14
Endogenous ligands for nuclear receptors: digging deeper. J Biol Chem (2010) 1.14
A novel adipose-specific gene deletion model demonstrates potential pitfalls of existing methods. Mol Endocrinol (2012) 1.13